D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVSA
1926
Covista Inc
CVSA
$4.3B
| $5.21M | ﹤0.01% |
137,767
-43,486
| -24% | -$1.61M |
|
|
CAS
1927
DELISTED
Cascade Acquisition Corp.
CAS
| $5.2M | ﹤0.01% |
522,811
+338,929
| +184% | +$3.35M |
|
1928
Standard BioTools
LAB
$311M
| $5.2M | ﹤0.01% |
789,207
+78,477
| +11% | +$516K |
|
|
MRTX
1929
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.2M | ﹤0.01% |
29,400
-20,000
| -40% | -$3.22M |
|
1930
Bio-Rad Laboratories Class A
BIO
$8.86B
| $5.17M | ﹤0.01% |
6,938
-6,246
| -47% | -$4.68M |
|
1931
CALL
General Dynamics
GD
$106B
| $5.17M | ﹤0.01% |
26,400
+16,400
| +164% | +$3.21M |
|
|
BIOT
1932
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
| $5.16M | ﹤0.01% |
529,830
+346,182
| +189% | +$3.36M |
|
1933
Beam Therapeutics
BEAM
$2.7B
| $5.16M | ﹤0.01% |
+59,243
| New | +$5.95M |
|
|
GWB
1934
DELISTED
Great Western Bancorp, Inc.
GWB
| $5.15M | ﹤0.01% |
157,324
+71,319
| +83% | +$2.2M |
|
|
EGRX
1935
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $5.14M | ﹤0.01% |
92,103
-32,865
| -26% | -$1.62M |
|
1936
CALL
Fidelity National Information Services
FIS
$23.2B
| $5.13M | ﹤0.01% |
+42,200
| New | +$5.66M |
|
|
SBNY
1937
DELISTED
Signature Bank
SBNY
| $5.13M | ﹤0.01% |
18,842
+15,463
| +458% | +$3.88M |
|
1938
Ubiquiti
UI
$32.4B
| $5.13M | ﹤0.01% |
17,164
+383
| +2% | +$118K |
|
1939
PUT
Martin Marietta Materials
MLM
$35B
| $5.13M | ﹤0.01% |
15,000
| – | – |
|
|
PPLI
1940
CALL
People Inc
PPLI
$3.13B
| $5.12M | ﹤0.01% |
47,907
| – | – |
|
|
ZGNX
1941
DELISTED
Zogenix, Inc.
ZGNX
| $5.12M | ﹤0.01% |
336,883
-375,701
| -53% | -$5.87M |
|
1942
Hanmi Financial
HAFC
$947M
| $5.12M | ﹤0.01% |
255,068
-8,329
| -3% | -$154K |
|
1943
LivaNova
LIVN
$4.51B
| $5.11M | ﹤0.01% |
64,576
+35,122
| +119% | +$2.89M |
|
1944
Brookfield
BN
$104B
| $5.1M | ﹤0.01% |
+176,922
| New | +$5.17M |
|
1945
Arcosa
ACA
$7.13B
| $5.09M | ﹤0.01% |
101,517
+9,741
| +11% | +$505K |
|
1946
CALL
Valero Energy
VLO
$88.7B
| $5.08M | ﹤0.01% |
72,000
| – | – |
|
|
PXD
1947
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
| $5.08M | ﹤0.01% |
30,500
+4,400
| +17% | +$666K |
|
1948
CALL
Dillards
DDS
$9.2B
| $5.07M | ﹤0.01% |
29,400
-1,200
| -4% | -$228K |
|
|
ACBI
1949
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $5.06M | ﹤0.01% |
191,047
-76,134
| -28% | -$1.86M |
|
1950
Banner Corp
BANR
$2.4B
| $5.06M | ﹤0.01% |
91,631
-6,859
| -7% | -$369K |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.